speb/financial-data huggingface dataset:
Financial ratios for AFN.TO — annual report dated 2025-12-31
Total revenue: 1036868613.1386861
Gross profit: 277778102.189781
Operating income: 79433576.64233576
Net income: -17492700.729927007
Capital expenditures: 13688321.16788321
Operating cash flow: -58127007.29927007
Depreciation & amortization: 51180291.97080292
Net tangible assets: -190781021.8978102
Owner earnings: 19999270.072992705
Capex to operating income (%): 17.232411967948245
Buffett classification: The Great
Stock price: 16.934306569343065
Shares outstanding: 18861297
Book value: 186674452.55474448
P/B ratio: 1.7110160566816819
Market cap (USD): 319402985.69343066
Debt to equity: 3.939388607357358
Current ratio: 1.2854236864842876
Quick ratio: 0.8944373840660127
Interest coverage ratio: 1.5348292737965954
COGS to revenue (%): 73.20990348536792
SG&A to revenue (%): 17.651477286326745
Free cash flow (dilution-adjusted): -86735766.42335765
Buyback yield (%): 2.0626986794064637
Retained earnings: -235408759.12408757
Inventory turnover: 5.357025483055081
Receivables turnover: 4.6214834841283015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.940240117380496
FCF margin (%): -8.36516462397308
Revenue growth (%): 5.553835553487032
Rule of 40 score: -2.811329070486048
Financial ratios for AMJLAND.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.39878675985757617
Shares outstanding: 41000000
Market cap (USD): 16350257.154160623
Buyback yield (%): 0
Retained earnings: 9425623.104312278
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMJLAND.NS — annual report dated 2023-03-31
Total revenue: 4304750.3045067
Gross profit: 2273264.31181486
Operating income: 923386.114494519
Net income: 863495.7369062119
Capital expenditures: 189001.2180267966
Operating cash flow: -702691.839220463
Depreciation & amortization: 225907.4299634592
Net tangible assets: 17705554.202192448
Owner earnings: 900401.9488428745
Return on net tangible assets (%): 5.085420871668504
Capex to operating income (%): 20.468275953040493
Buffett classification: The Great
Stock price: 0.25468940316686967
P/E ratio: 12.09301341458254
Shares outstanding: 41000000
Book value: 17804177.831912305
P/B ratio: 0.5865064721564892
Market cap (USD): 10442265.529841656
Debt to equity: 0.03420620733203212
Current ratio: 3.5849228640045587
Quick ratio: 1.2529002320185614
Effective tax rate (%): 32.63234916803664
Interest coverage ratio: 12.253111362534346
COGS to revenue (%): 47.191726557636805
R&D to revenue (%): 1.8411521702223983
SG&A to revenue (%): 5.811499066266765
Free cash flow (dilution-adjusted): -921181.485992692
Buyback yield (%): 0
Retained earnings: 9446309.378806334
Inventory turnover: 0.2911200402158811
Receivables turnover: 29.344071736964466
Capitalized R&D asset: 79257.0036540804
ROCI (R&D-adjusted, %): 5.124457410955934
FCF margin (%): -21.39918510554015
Rule of 40 score: -21.39918510554015
Financial ratios for AMJLAND.NS — annual report dated 2024-03-31
Total revenue: 6770416.1170404125
Gross profit: 2999844.1060079145
Operating income: 1449550.3057920614
Net income: 1383295.3591557741
Capital expenditures: 11764.000479673821
Operating cash flow: 2857608.825998321
Depreciation & amortization: 227065.5953951313
Net tangible assets: 21424115.601391055
Owner earnings: 1598596.9540712317
Return on net tangible assets (%): 7.461670688368745
Capex to operating income (%): 0.8115620708482932
Buffett classification: The Great
Stock price: 0.40319097888675626
P/E ratio: 11.950325738420593
Shares outstanding: 41000000
Book value: 21569564.696006715
P/B ratio: 0.7663960940953733
Market cap (USD): 16530830.134357007
Debt to equity: 0.08339421110744176
Current ratio: 3.430402673174043
Quick ratio: 2.097043006033368
Effective tax rate (%): 20.21179465187378
Interest coverage ratio: 6.846672330784481
COGS to revenue (%): 55.69187987636936
R&D to revenue (%): 0.44492857585660267
SG&A to revenue (%): 5.0739924014984465
Free cash flow (dilution-adjusted): 2845844.825518647
Buyback yield (%): 0
Retained earnings: 10544969.42079386
Inventory turnover: 0.6899935702890299
Receivables turnover: 28.527360921631043
Capitalized R&D asset: 83225.70845734767
ROCI (R&D-adjusted, %): 6.134097106549352
Rosenberg metric: 9.167389135277359
FCF margin (%): 42.03352905231276
Revenue growth (%): 57.277789374969664
Rule of 40 score: 99.31131842728243
Financial ratios for AMJLAND.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 27295150.50167224
Buffett classification: The Gruesome
Stock price: 0.6028428093645485
Shares outstanding: 41000000
Book value: 27473960.82178691
P/B ratio: 0.8996356711823731
Market cap (USD): 24716555.183946487
Debt to equity: 0.04117437351094726
Current ratio: 4.3271759238025345
Quick ratio: 3.0404646149612438
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMJLAND.NS — quarterly report dated 2025-03-31
Total revenue: 2987175.5903670797
Gross profit: 2193242.9272854803
Operating income: 1767968.202010755
Net income: 1283726.9113864857
Capital expenditures: 0
Depreciation & amortization: 55097.03062894552
Net tangible assets: 26525298.106149167
Owner earnings: 1338823.9420154311
Return on net tangible assets (%): 5.047347391376014
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5301668806161746
P/E ratio: 4.2331515200897245
Shares outstanding: 41000000
Book value: 26658393.733925648
P/B ratio: 0.8153845397519471
Market cap (USD): 21736842.10526316
Debt to equity: 0
Current ratio: 4.0516613227611815
Quick ratio: 3.2033232880761298
Effective tax rate (%): 35.28787789498497
COGS to revenue (%): 26.578037984838936
Buyback yield (%): 0
Retained earnings: 12554489.127893383
Inventory turnover: 0.2571955523911957
Receivables turnover: 6.192995637421232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.345828165151319
Rule of 40 score: 0
Financial ratios for AMJLAND.NS — annual report dated 2025-03-31
Total revenue: 9084054.24362871
Gross profit: 4564496.142155716
Operating income: 2956944.119710077
Net income: 2505097.030628945
Capital expenditures: 69978.95721299975
Operating cash flow: 4454056.581716156
Depreciation & amortization: 220388.12251578207
Net tangible assets: 26525298.106149167
Owner earnings: 2655506.1959317275
Return on net tangible assets (%): 10.011220930693785
Capex to operating income (%): 2.366597215907518
Buffett classification: The Great
Stock price: 0.5301668806161746
P/E ratio: 8.677045974465017
Shares outstanding: 41000000
Book value: 26658393.733925648
P/B ratio: 0.8153845397519471
Market cap (USD): 21736842.10526316
Debt to equity: 0
Current ratio: 4.0516613227611815
Quick ratio: 3.2033232880761298
Effective tax rate (%): 33.58479572038705
Interest coverage ratio: 27.25320547354811
COGS to revenue (%): 49.752654269352035
R&D to revenue (%): 0.2648478218904832
SG&A to revenue (%): 3.1149861656264077
Free cash flow (dilution-adjusted): 4381365.44306757
Buyback yield (%): 0
Retained earnings: 12554489.127893383
Inventory turnover: 1.4641169163649583
Receivables turnover: 18.83301017935046
Capitalized R&D asset: 70396.48673555344
ROCI (R&D-adjusted, %): 10.51359691579855
Rosenberg metric: 51.94121548342563
FCF margin (%): 48.2313879415739
Revenue growth (%): 34.1727611212126
Rule of 40 score: 82.4041490627865
Financial ratios for AMJLAND.NS — quarterly report dated 2025-06-30
Total revenue: 1669424.292066464
Gross profit: 829873.6250877604
Operating income: 410250.40954832674
Net income: 423227.24081441615
Capital expenditures: 0
Depreciation & amortization: 54867.7743973789
Owner earnings: 478095.01521179505
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7672595366253218
P/E ratio: 18.582003926013986
Shares outstanding: 41000000
Market cap (USD): 31457641.001638193
Effective tax rate (%): 33.50553369856969
COGS to revenue (%): 50.28983170835991
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -44.11362032248943
Rule of 40 score: -44.11362032248943
Financial ratios for AMJLAND.NS — quarterly report dated 2025-09-30
Total revenue: 1247001.1273957158
Gross profit: 614069.8985343856
Operating income: 281837.6550169109
Net income: 556009.0191657272
Capital expenditures: 0
Depreciation & amortization: 52559.188275084554
Net tangible assets: 28633258.17361894
Owner earnings: 608568.2074408118
Return on net tangible assets (%): 2.1253893069057437
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6098083427282976
P/E ratio: 11.04840872720042
Shares outstanding: 41000000
Book value: 28787914.317925587
P/B ratio: 0.8684943888516414
Market cap (USD): 25002142.051860202
Debt to equity: 0
Current ratio: 4.453152298707133
Quick ratio: 3.7305845355163982
Effective tax rate (%): 26.301947130112524
COGS to revenue (%): 50.75626757316313
Buyback yield (%): 0
Inventory turnover: 0.2585617700158432
Receivables turnover: 3.4700862745098036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9317426483496128
Revenue growth (%): -25.3035232971158
Rule of 40 score: -25.3035232971158
Financial ratios for AMJLAND.NS — quarterly report dated 2025-12-31
Total revenue: 1316519.9955441684
Gross profit: 497560.43221566227
Operating income: 11017.043555753593
Net income: 151531.69210203856
Capital expenditures: 0
Depreciation & amortization: 51932.71694329954
Owner earnings: 203464.4090453381
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5822657903531248
P/E ratio: 9.887325819439626
Shares outstanding: 41000000
Market cap (USD): 23872897.404478114
Effective tax rate (%): 32.57831086439333
COGS to revenue (%): 62.20639003587626
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.574884145745596
Rule of 40 score: 5.574884145745596
Financial ratios for ARYN.SW — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 53.098901098901095
Shares outstanding: 24824648
Market cap (USD): 1318161528.967033
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARYN.SW — annual report dated 2022-07-31
Total revenue: 1848526315.7894738
Gross profit: 335263157.8947369
Operating income: 94842105.2631579
Net income: 947368.4210526316
Capital expenditures: 82631578.94736843
Operating cash flow: 210631578.94736844
Depreciation & amortization: 130315789.47368422
Net tangible assets: 278842105.2631579
Owner earnings: 48631578.94736843
Return on net tangible assets (%): 17.440543601359003
Capex to operating income (%): 87.12541620421753
Buffett classification: The Gruesome
Stock price: 45.6
P/E ratio: 1194.8930570666666
Shares outstanding: 24824648
Book value: 981473684.2105265
P/B ratio: 1.1533716767052764
Market cap (USD): 1132003948.8
Debt to equity: 0.5746460746460745
Current ratio: 1.0019208605455245
Quick ratio: 0.7706492508643873
Effective tax rate (%): 91.62995594713657
Interest coverage ratio: 4.896739130434783
COGS to revenue (%): 81.86321963441718
SG&A to revenue (%): 13.006093047092989
Free cash flow (dilution-adjusted): 112526315.78947368
Buyback yield (%): 0
Retained earnings: -1385684210.526316
Inventory turnover: 11.940199335548174
Receivables turnover: 16.901828681424448
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.768245838668374
FCF margin (%): 6.087352656454644
Rule of 40 score: 6.087352656454644
Financial ratios for ARYN.SW — annual report dated 2023-07-31
Total revenue: 2440459770.1149426
Gross profit: 450919540.22988504
Operating income: 165287356.3218391
Net income: 128735632.18390805
Capital expenditures: 57816091.95402299
Operating cash flow: 288965517.2413793
Depreciation & amortization: 146551724.13793105
Net tangible assets: 163793103.44827586
Owner earnings: 217471264.3678161
Return on net tangible assets (%): 132.7719298245614
Capex to operating income (%): 34.979137691237824
Buffett classification: The Good
Stock price: 68.45977011494253
P/E ratio: 13.201393168571428
Shares outstanding: 24824648
Book value: 911839080.4597702
P/B ratio: 1.863804405496029
Market cap (USD): 1699489695.2643678
Debt to equity: 0.6616664565738056
Current ratio: 0.7465944813133077
Quick ratio: 0.5207823960880196
Effective tax rate (%): 7.742998352553541
Interest coverage ratio: 4.565079365079366
COGS to revenue (%): 81.5231725697061
SG&A to revenue (%): 11.704031650339113
Free cash flow (dilution-adjusted): 217586206.89655173
Buyback yield (%): 0.033816777193742285
Retained earnings: -867701149.4252874
Inventory turnover: 13.386697602474865
Receivables turnover: 17.917299578059072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.313418919888116
FCF margin (%): 8.915787490580257
Revenue growth (%): 32.02191114453592
Rule of 40 score: 40.93769863511618
Financial ratios for ARYN.SW — annual report dated 2024-12-31
Total revenue: 2438333333.3333335
Gross profit: 521333333.3333333
Operating income: 211111111.1111111
Net income: 144000000
Capital expenditures: 90666666.66666667
Operating cash flow: 332111111.1111111
Depreciation & amortization: 145444444.44444445
Net tangible assets: -200777777.77777776
Owner earnings: 198777777.77777773
Return on net tangible assets (%): -99.0038738240177
Capex to operating income (%): 42.94736842105264
Buffett classification: The Good
Stock price: 70.44444444444444
P/E ratio: 12.14415650617284
Shares outstanding: 24824648
Book value: 502333333.33333325
P/B ratio: 3.4812711417827917
Market cap (USD): 1748758536.8888888
Debt to equity: 1.805795178057952
Current ratio: 0.636571227823643
Quick ratio: 0.4117337080625329
Effective tax rate (%): 16.007777057679846
Interest coverage ratio: 3.4050179211469533
COGS to revenue (%): 78.61927546138072
SG&A to revenue (%): 12.722715880610616
Free cash flow (dilution-adjusted): 220111111.1111111
Buyback yield (%): 0.6163102309683002
Retained earnings: -1372000000
Inventory turnover: 13.478906250000001
Receivables turnover: 20.528531337698787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.161138853693075
FCF margin (%): 9.027113237639552
Revenue growth (%): -0.08713262999245859
Rule of 40 score: 8.939980607647094
Financial ratios for ARYN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -200777777.77777776
Buffett classification: The Gruesome
Stock price: 70.44444444444444
Shares outstanding: 24824648
Book value: 502333333.33333325
P/B ratio: 3.4812711417827917
Market cap (USD): 1748758536.8888888
Debt to equity: 1.805795178057952
Current ratio: 0.636571227823643
Quick ratio: 0.4117337080625329
Buyback yield (%): 0
Retained earnings: -1372000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARYN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -159125000
Buffett classification: The Gruesome
Stock price: 101.06249999999999
Shares outstanding: 24824648
Book value: 620000000
P/B ratio: 4.046517723387096
Market cap (USD): 2508840988.4999995
Debt to equity: 1.6278225806451614
Current ratio: 0.6537313432835821
Quick ratio: 0.41436567164179106
Buyback yield (%): 0
Retained earnings: -1315250000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNKK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.15
Shares outstanding: 8000940
Market cap (USD): 249229281
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNKK — annual report dated 2022-12-31
Total revenue: 120627
Gross profit: -204542
Operating income: -11833326
Net income: -15223028
Capital expenditures: 14991
Operating cash flow: -6375628
Depreciation & amortization: 20589
Net tangible assets: 3665594
Owner earnings: -15217430
Return on net tangible assets (%): -415.1422661647744
Buffett classification: The Gruesome
Stock price: 26.95
Shares outstanding: 8000940
Book value: 3665594
P/B ratio: 58.82411772825905
Market cap (USD): 215625333
Debt to equity: 0.7451348949174403
Current ratio: 1.4984960637086588
Quick ratio: 1.4649362669264967
Interest coverage ratio: -9.199020808975348
COGS to revenue (%): 269.5656859575385
SG&A to revenue (%): 9640.282855413798
Free cash flow (dilution-adjusted): -9620192
Buyback yield (%): 1.3356709807376854
Retained earnings: -50597674
Inventory turnover: 2.150531731964763
Receivables turnover: 0.08121094365383605
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -282.73860624435366
FCF margin (%): -7975.156474089549
Rule of 40 score: -7975.156474089549
Financial ratios for BNKK — annual report dated 2023-12-31
Total revenue: 202670
Gross profit: -74457
Operating income: -12599326
Net income: -15083041
Capital expenditures: 0
Operating cash flow: -10113777
Depreciation & amortization: 214142
Net tangible assets: 4306079
Owner earnings: -14868899
Return on net tangible assets (%): -345.3001907303605
Buffett classification: The Gruesome
Stock price: 122.85
Shares outstanding: 8000940
Book value: 8817136
P/B ratio: 111.47786299315332
Market cap (USD): 982915479
Debt to equity: 0.23461507228651118
Current ratio: 2.1440006333741923
Quick ratio: 1.9221457111897315
Interest coverage ratio: -73.49416973394854
COGS to revenue (%): 136.73804707159422
SG&A to revenue (%): 6179.932402427592
Free cash flow (dilution-adjusted): -13431932
Buyback yield (%): 0
Retained earnings: -65680715
Inventory turnover: 0.3482264922897525
Receivables turnover: 36.288272157564904
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -138.1195637863141
FCF margin (%): -6627.489021562145
Revenue growth (%): 68.01379458993426
Rule of 40 score: -6559.475226972211
Financial ratios for BNKK — quarterly report dated 2024-09-30
Operating income: -11630093
Capital expenditures: 62912
Depreciation & amortization: 109033
Buffett classification: The Gruesome
Stock price: 42.7
Shares outstanding: 8000940
Market cap (USD): 341640138
Buyback yield (%): 0
Capitalized R&D asset: 10315
ROCI (R&D-adjusted, %): -112682.65955727904
Rule of 40 score: 0
Financial ratios for BNKK — annual report dated 2024-12-31
Total revenue: 701967
Gross profit: -2445757
Operating income: -42057672
Net income: -49409632
Capital expenditures: 87162
Operating cash flow: -19087550
Depreciation & amortization: 428828
Net tangible assets: -6537373
Owner earnings: -49067966
Buffett classification: The Gruesome
Stock price: 25.2
Shares outstanding: 8000940
Book value: -2173052
Market cap (USD): 201623688
Debt to equity: -2.588543670376963
Current ratio: 0.27458430377979565
Quick ratio: 0.24973569555618433
Interest coverage ratio: -239.06320235097513
COGS to revenue (%): 448.414811522479
SG&A to revenue (%): 5642.988203149151
Free cash flow (dilution-adjusted): -24295012
Buyback yield (%): 0
Retained earnings: -115090347
Inventory turnover: 13.480039398740953
Receivables turnover: 0.8828463196657603
Capitalized R&D asset: 0
FCF margin (%): -3460.9906163680057
Revenue growth (%): 246.35959934869493
Rule of 40 score: -3214.631017019311
Financial ratios for BNKK — quarterly report dated 2024-12-31
Capital expenditures: 1497
Buffett classification: The Gruesome
Stock price: 25.2
Shares outstanding: 8000940
Market cap (USD): 201623688
Buyback yield (%): 0
Capitalized R&D asset: 6911.05
Rule of 40 score: 0
Financial ratios for BNKK — quarterly report dated 2025-03-31
Total revenue: 42101
Gross profit: 20989
Operating income: -5390336
Net income: -5326933
Capital expenditures: 63388
Operating cash flow: -4628114
Depreciation & amortization: 110792
Net tangible assets: -4868497
Owner earnings: -5279529
Buffett classification: The Gruesome
Stock price: 12.74
Shares outstanding: 8000940
Book value: -542638
Market cap (USD): 101931975.60000001
Debt to equity: -10.441574309207981
Current ratio: 0.4389016726334625
Quick ratio: 0.4019953238204274
Interest coverage ratio: -52.10571290478492
COGS to revenue (%): 50.14607729032564
R&D to revenue (%): 21.389040640364836
SG&A to revenue (%): 12568.651575972068
Free cash flow (dilution-adjusted): -5650752
Buyback yield (%): 0
Retained earnings: -120417280
Inventory turnover: 0.06227820469328456
Receivables turnover: 0.0765266800933567
Capitalized R&D asset: 12408.95
FCF margin (%): -13421.894966865395
Rule of 40 score: -13421.894966865395
Financial ratios for BNKK — quarterly report dated 2025-06-30
Total revenue: 44948
Gross profit: 23878
Operating income: -4309628
Net income: 13404955
Capital expenditures: 69672
Operating cash flow: -1653911
Depreciation & amortization: 110852
Net tangible assets: 3326207
Owner earnings: 13446135
Return on net tangible assets (%): 404.2482924243741
Buffett classification: The Gruesome
Stock price: 11.55
P/E ratio: 11.439787735165861
Shares outstanding: 8000940
Book value: 23088369
P/B ratio: 4.002485277327299
Market cap (USD): 92410857
Debt to equity: 0.454929189671215
Current ratio: 1.1593518679960055
Quick ratio: 1.1149245246133768
Interest coverage ratio: -31.134881301564825
COGS to revenue (%): 46.8763904956839
R&D to revenue (%): 14.49897659517665
SG&A to revenue (%): 9380.163744771737
Free cash flow (dilution-adjusted): -764333
Buyback yield (%): 0
Retained earnings: -107258403
Inventory turnover: 0.025057589643021516
Receivables turnover: 0.21902028525067854
Capitalized R&D asset: 12550.35
ROCI (R&D-adjusted, %): -18.607832839083233
Rosenberg metric: 0.3208217656857302
FCF margin (%): -1700.4827801014508
Revenue growth (%): 6.76230968385549
Rule of 40 score: -1693.7204704175954
Financial ratios for BNKK — quarterly report dated 2025-09-30
Total revenue: 2023902
Gross profit: 543142
Operating income: -16672424
Net income: -33581216
Capital expenditures: 60
Operating cash flow: -12778466
Depreciation & amortization: 202237
Net tangible assets: 55287778
Owner earnings: -33379039
Return on net tangible assets (%): -60.373269115644334
Buffett classification: The Gruesome
Stock price: 9.38
Shares outstanding: 8000940
Book value: 75519219
P/B ratio: 0.9937710981889261
Market cap (USD): 75048817.2
Debt to equity: 0.005051760400223418
Current ratio: 10.59200949867061
Quick ratio: 10.43069706110885
Interest coverage ratio: -60.91250991008765
COGS to revenue (%): 73.1665367196633
R&D to revenue (%): 0.4282816065204738
SG&A to revenue (%): 840.1919164070197
Free cash flow (dilution-adjusted): -13697095
Buyback yield (%): 0
Retained earnings: -140839619
Inventory turnover: 1.662270820494342
Receivables turnover: 0.091859993507762
Capitalized R&D asset: 16006.039999999999
ROCI (R&D-adjusted, %): -22.0715822644398
Rosenberg metric: 79.6783796225257
FCF margin (%): -676.7667110364039
Revenue growth (%): 4402.763193023049
Rule of 40 score: 3725.9964819866454
Financial ratios for BNKK — quarterly report dated 2025-12-31
Total revenue: 234620.71
Gross profit: -2184613.63
Operating income: -37910171.63
Net income: -42652558
Capital expenditures: 60
Operating cash flow: -6215244
Depreciation & amortization: 230556
Net tangible assets: 2210683
Owner earnings: -42422062
Return on net tangible assets (%): -1918.9572634339704
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 8000940
Book value: 34996344
P/B ratio: 0.5898451906862043
Market cap (USD): 20642425.2
Debt to equity: 0.009936866548117141
Current ratio: 1.0108671956548618
Quick ratio: 0.8520477672090561
Interest coverage ratio: -396.2846173064058
COGS to revenue (%): 498.08603852575504
SG&A to revenue (%): 4526.181427036002
Free cash flow (dilution-adjusted): -15752249
Buyback yield (%): 0
Retained earnings: -183492179
Inventory turnover: 1.2310584393352821
Receivables turnover: 1.0221120477466292
Capitalized R&D asset: 7958.17
ROCI (R&D-adjusted, %): -108.31592388995387
Rosenberg metric: -314.69261998154127
FCF margin (%): -6713.920949263175
Revenue growth (%): -88.40750639111972
Rule of 40 score: -6802.328455654295
Financial ratios for BNKK — annual report dated 2025-12-31
Total revenue: 506941.37
Gross profit: -2184613.63
Operating income: -37910171.63
Net income: -68185762
Capital expenditures: 0
Operating cash flow: -25275735
Depreciation & amortization: 654378
Net tangible assets: 2210683
Owner earnings: -67531384
Return on net tangible assets (%): -3054.7746556154816
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 8000940
Book value: 34996344
P/B ratio: 0.5898451906862043
Market cap (USD): 20642425.2
Debt to equity: 0.009936866548117141
Current ratio: 1.0108671956548618
Quick ratio: 0.8520477672090561
Interest coverage ratio: -63.98298008114713
COGS to revenue (%): 530.9400966821863
SG&A to revenue (%): 7047.276098220194
Free cash flow (dilution-adjusted): -35864429
Buyback yield (%): 0
Retained earnings: -183492179
Inventory turnover: 2.8353796318242868
Receivables turnover: 2.2084618266570826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -108.32609151973132
FCF margin (%): -7074.669995861652
Revenue growth (%): -27.78273480092369
Rule of 40 score: -7102.452730662576
Financial ratios for CNEY — annual report dated 2021-09-30
Capital expenditures: 647196.599690881
Buffett classification: The Gruesome
Stock price: 4545
Shares outstanding: 7567888
Market cap (USD): 34396050960
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNEY — annual report dated 2022-09-30
Total revenue: 5646851.9662921345
Gross profit: 511466.43258426967
Operating income: 294426.96629213484
Net income: 313161.23595505615
Capital expenditures: 549872.7528089888
Operating cash flow: -1055424.0168539325
Depreciation & amortization: 215968.11797752808
Net tangible assets: 8845235.95505618
Owner earnings: -20743.398876404623
Return on net tangible assets (%): -0.23451492963901238
Capex to operating income (%): 186.76032285147306
Buffett classification: The Gruesome
Stock price: 1582.5
P/E ratio: 38242.86464918277
Shares outstanding: 7567888
Book value: 8958191.853932586
P/B ratio: 1336.8973287553042
Market cap (USD): 11976182760
Debt to equity: 0.06587056734180562
Current ratio: 2.43640930886803
Quick ratio: 2.4106636914608437
Effective tax rate (%): 12.353590691125445
Interest coverage ratio: 13.33358775227228
COGS to revenue (%): 90.9424501361577
R&D to revenue (%): 2.5677476756588007
SG&A to revenue (%): 5.346107876651768
Free cash flow (dilution-adjusted): -1605296.7696629213
Buyback yield (%): 0
Retained earnings: 339234.41011235956
Inventory turnover: 46.62275853011345
Receivables turnover: 2.129443038930715
Capitalized R&D asset: 144996.91011235956
ROCI (R&D-adjusted, %): 4.250429794423422
FCF margin (%): -28.428171647591462
Rule of 40 score: -28.428171647591462
Financial ratios for CNEY — annual report dated 2023-09-30
Total revenue: 7931383.01369863
Gross profit: 108034.24657534246
Operating income: -719511.7808219178
Net income: -770649.3150684931
Capital expenditures: 93615.34246575342
Operating cash flow: -4132187.808219178
Depreciation & amortization: 378061.7808219178
Net tangible assets: 13274727.123287672
Owner earnings: -486202.87671232875
Return on net tangible assets (%): -3.662620498310581
Buffett classification: The Gruesome
Stock price: 90
Shares outstanding: 7567888
Book value: 14186607.397260277
P/B ratio: 48.01076824974633
Market cap (USD): 681109920
Debt to equity: 0.07037309565956253
Current ratio: 3.2281109214477213
Quick ratio: 3.1098022703465227
Interest coverage ratio: -7.371943465873205
COGS to revenue (%): 98.63788892317075
R&D to revenue (%): 1.707382443415006
SG&A to revenue (%): 9.988333842034425
Free cash flow (dilution-adjusted): -4225803.150684931
Buyback yield (%): 0
Retained earnings: -439984.2465753425
Inventory turnover: 21.508638224969335
Receivables turnover: 1.9956351778552315
Capitalized R&D asset: 232566.97087117133
ROCI (R&D-adjusted, %): -4.690599317694463
Rosenberg metric: -2.7823502286793804
FCF margin (%): -53.27952443333485
Revenue growth (%): 40.45671926665675
Rule of 40 score: -12.822805166678101
Financial ratios for CNEY — annual report dated 2024-09-30
Total revenue: 7269325.820256776
Gross profit: -25836.091298145508
Operating income: -1769858.6305278174
Net income: -2002962.7674750357
Capital expenditures: 0
Operating cash flow: -338255.634807418
Depreciation & amortization: 372732.0970042796
Net tangible assets: 12939673.038516406
Owner earnings: -1630230.670470756
Return on net tangible assets (%): -12.598700644275858
Buffett classification: The Gruesome
Stock price: 21
Shares outstanding: 7567888
Book value: 13824881.16975749
P/B ratio: 11.495624884476879
Market cap (USD): 158925648
Debt to equity: 0
Current ratio: 42.41019689136322
Quick ratio: 39.90307629393782
Interest coverage ratio: -36.9294552576669
COGS to revenue (%): 100.35541248166578
R&D to revenue (%): 0.26521070088069043
SG&A to revenue (%): 6.270830155060716
Free cash flow (dilution-adjusted): -338255.634807418
Buyback yield (%): 0
Retained earnings: -2388220.684736091
Inventory turnover: 14.066403469298162
Receivables turnover: 1.6707691866830596
Capitalized R&D asset: 157858.76782852923
ROCI (R&D-adjusted, %): -13.234015192198672
Rosenberg metric: -0.9885636228858996
FCF margin (%): -4.653191274833651
Revenue growth (%): -8.347310832151047
Rule of 40 score: -13.000502106984698
Financial ratios for CNEY — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 12939673.038516406
Buffett classification: The Gruesome
Stock price: 21
Shares outstanding: 7567888
Book value: 13824881.16975749
P/B ratio: 11.495624884476879
Market cap (USD): 158925648
Debt to equity: 0
Current ratio: 42.41019689136322
Quick ratio: 39.90307629393782
Buyback yield (%): 0
Retained earnings: -2388220.684736091
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVVY.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24409448818897636
Shares outstanding: 309088041
Market cap (USD): 75446687.17322834
Buyback yield (%): 0
Capitalized R&D asset: 3740157.4803149607
Rule of 40 score: 0
Financial ratios for CVVY.TO — annual report dated 2022-12-31
Total revenue: 381628676.4705882
Gross profit: 284841911.76470584
Operating income: 87242647.05882353
Net income: 107808823.52941176
Capital expenditures: 29063235.294117644
Operating cash flow: 64828676.47058823
Depreciation & amortization: 41322794.11764706
Net tangible assets: 84631617.64705881
Owner earnings: 120068382.35294117
Return on net tangible assets (%): 141.87177994595956
Capex to operating income (%): 33.313105773282764
Buffett classification: The Good
Stock price: 0.9191176470588235
P/E ratio: 2.635111521279498
Shares outstanding: 309088041
Book value: 84380882.35294116
P/B ratio: 3.3667374061067643
Market cap (USD): 284088272.97794116
Debt to equity: 1.8032991164014713
Current ratio: 0.36897317983113986
Quick ratio: 0.359880708641925
Effective tax rate (%): -116.6275135558412
Interest coverage ratio: 3.9157123527276325
COGS to revenue (%): 25.3615020760479
R&D to revenue (%): -0.869724381761606
SG&A to revenue (%): 5.664961513636407
Free cash flow (dilution-adjusted): 35427205.88235294
Buyback yield (%): 0
Retained earnings: -130705882.35294117
Inventory turnover: 42.16207559256886
Receivables turnover: 6.965335373218455
Capitalized R&D asset: -813212.1352477991
ROCI (R&D-adjusted, %): 42.08405920980591
FCF margin (%): 9.283161372985367
Rule of 40 score: 9.283161372985367
Financial ratios for CVVY.TO — annual report dated 2023-12-31
Total revenue: 285993181.8181818
Gross profit: 232279545.45454544
Operating income: 27644696.96969697
Net income: 6803787.878787879
Capital expenditures: 42075000
Operating cash flow: 78940909.0909091
Depreciation & amortization: 46616666.666666664
Net tangible assets: 132384090.9090909
Owner earnings: 11345454.545454547
Return on net tangible assets (%): 8.570104207797561
Capex to operating income (%): 152.19917239867365
Buffett classification: The Gruesome
Stock price: 0.26515151515151514
P/E ratio: 12.045519914263444
Shares outstanding: 309088041
Book value: 132125757.57575756
P/B ratio: 0.6202814946160109
Market cap (USD): 81955162.38636363
Debt to equity: 1.0075742807013521
Current ratio: 0.8732562822656431
Quick ratio: 0.8509464588647375
Effective tax rate (%): -75.13650546021839
Interest coverage ratio: 1.4762328573162344
COGS to revenue (%): 18.781439481233658
R&D to revenue (%): 0
SG&A to revenue (%): 6.488287758502401
Free cash flow (dilution-adjusted): 36567424.242424235
Buyback yield (%): 0
Retained earnings: -127862878.78787878
Inventory turnover: 19.393326039387308
Receivables turnover: 6.136095443980301
Capitalized R&D asset: -989556.8550254744
ROCI (R&D-adjusted, %): 7.669782463517208
FCF margin (%): 12.786117490616164
Revenue growth (%): -25.05982923947722
Rule of 40 score: -12.273711748861057
Financial ratios for CVVY.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1925925925925926
Shares outstanding: 309088041
Market cap (USD): 59528067.155555554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVVY.TO — annual report dated 2024-12-31
Total revenue: 155784615.3846154
Gross profit: 98980419.58041959
Operating income: -63211188.81118882
Net income: -27206293.706293706
Capital expenditures: 17969930.06993007
Operating cash flow: 4987412.587412587
Depreciation & amortization: 41649650.34965035
Net tangible assets: 117781818.18181819
Owner earnings: -3526573.426573422
Return on net tangible assets (%): -2.9941577409931797
Buffett classification: The Gruesome
Stock price: 0.18881118881118883
Shares outstanding: 309088041
Book value: 117781818.18181819
P/B ratio: 0.4954863269171397
Market cap (USD): 58359280.468531474
Debt to equity: 1.0242418125252335
Current ratio: 0.9730583394512642
Quick ratio: 0.9408581038397841
Interest coverage ratio: -3.5989807294155125
COGS to revenue (%): 36.46328982098289
SG&A to revenue (%): 11.599752213024976
Free cash flow (dilution-adjusted): -14000699.300699301
Buyback yield (%): 0
Retained earnings: -145472027.972028
Inventory turnover: 21.534994697773065
Receivables turnover: 4.44069688633736
Capitalized R&D asset: -1095308.8235294118
ROCI (R&D-adjusted, %): -17.988098338387754
FCF margin (%): -8.987215628535004
Revenue growth (%): -45.52855617248442
Rule of 40 score: -54.515771801019426
Financial ratios for CVVY.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18881118881118883
Shares outstanding: 309088041
Market cap (USD): 58359280.468531474
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVVY.TO — quarterly report dated 2025-03-31
Total revenue: 42016083.91608392
Gross profit: 33044755.244755246
Operating income: -6307692.307692308
Net income: 1864335.6643356644
Capital expenditures: 4574825.174825175
Operating cash flow: 15812587.412587414
Depreciation & amortization: 8971328.671328671
Net tangible assets: 93044055.94405594
Owner earnings: 6260839.160839161
Return on net tangible assets (%): 6.728897507008486
Buffett classification: The Gruesome
Stock price: 0.2377622377622378
P/E ratio: 9.85464496811703
Shares outstanding: 309088041
Book value: 93044055.94405591
P/B ratio: 0.7898351329169582
Market cap (USD): 73489464.2937063
Debt to equity: 1.1990635310740836
Current ratio: 0.6870614868834894
Quick ratio: 0.6553848546642241
Effective tax rate (%): 36.05181098584793
Interest coverage ratio: -1.5871898645081823
COGS to revenue (%): 21.352129554116807
SG&A to revenue (%): 11.682172994024933
Free cash flow (dilution-adjusted): 11170629.370629372
Buyback yield (%): 0
Retained earnings: -143607692.30769232
Inventory turnover: 3.499454446262957
Receivables turnover: 1.3565203648514403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9792073515923627
FCF margin (%): 26.586555265216454
Rule of 40 score: 26.586555265216454
Financial ratios for CVVY.TO — quarterly report dated 2025-06-30
Total revenue: 43492700.729927
Gross profit: 29818248.17518248
Operating income: -9256934.306569342
Net income: 3027007.299270073
Capital expenditures: 1745255.4744525547
Operating cash flow: 1167153.2846715327
Depreciation & amortization: 10406569.343065692
Net tangible assets: 116310948.90510948
Owner earnings: 11688321.16788321
Return on net tangible assets (%): 10.049201109535225
Buffett classification: The Gruesome
Stock price: 0.27007299270072993
P/E ratio: 17.066137635816055
Shares outstanding: 309088041
Book value: 116310948.90510947
P/B ratio: 0.7176996923047959
Market cap (USD): 83476332.24087591
Debt to equity: 0.948997778419289
Current ratio: 0.8904290297112818
Quick ratio: 0.8537621298581892
Effective tax rate (%): 19.694035631293573
Interest coverage ratio: -2.5998359983599837
COGS to revenue (%): 31.440798858773185
SG&A to revenue (%): 12.645800117479233
Free cash flow (dilution-adjusted): -623357.6642335766
Buyback yield (%): 0
Retained earnings: -146870072.99270073
Inventory turnover: 5.106023439629327
Receivables turnover: 1.6035577802895744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.79861327189713
FCF margin (%): -1.4332466224720988
Revenue growth (%): 3.514408474602822
Rule of 40 score: 2.081161852130723
Financial ratios for CVVY.TO — quarterly report dated 2025-09-30
Total revenue: 33600719.42446043
Gross profit: 22935251.798561152
Operating income: -16128776.978417268
Net income: -7256115.107913669
Capital expenditures: 2893525.1798561155
Operating cash flow: 3212949.64028777
Depreciation & amortization: 9788489.208633095
Net tangible assets: 99243165.4676259
Owner earnings: -361151.07913668966
Return on net tangible assets (%): -0.3639052396555214
Buffett classification: The Gruesome
Stock price: 0.5395683453237411
Shares outstanding: 309088041
Book value: 99243165.46762592
P/B ratio: 1.6804595264157507
Market cap (USD): 166774122.84172663
Debt to equity: 1.1428291820106127
Current ratio: 0.9192679945826314
Quick ratio: 0.8785936863431661
Interest coverage ratio: -4.479320679320679
COGS to revenue (%): 31.741783534953434
SG&A to revenue (%): 26.48752810191628
Free cash flow (dilution-adjusted): 274100.71942446043
Buyback yield (%): 0
Retained earnings: -152012949.6402878
Inventory turnover: 4.013264753654575
Receivables turnover: 1.2629799891833422
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.03283159915143
FCF margin (%): 0.8157584841023444
Revenue growth (%): -22.744003337231185
Rule of 40 score: -21.92824485312884
Financial ratios for CVVY.TO — annual report dated 2025-12-31
Total revenue: 166537226.27737224
Gross profit: 129093430.65693429
Operating income: -33067153.28467153
Net income: -3555474.452554744
Capital expenditures: 17050364.963503648
Operating cash flow: 26608029.197080288
Depreciation & amortization: 29968613.138686128
Net tangible assets: 101129197.08029196
Owner earnings: 9362773.722627737
Buffett classification: The Gruesome
Stock price: 0.6642335766423357
Shares outstanding: 309088041
Book value: 101129197.08029199
P/B ratio: 2.0301422427768188
Market cap (USD): 205306654.9708029
Debt to equity: 1.1212584898987346
Current ratio: 0.7878208455115773
Quick ratio: 0.7533757637010935
Effective tax rate (%): 309.23539518900344
Interest coverage ratio: -2.209207061347898
COGS to revenue (%): 22.483739195988708
SG&A to revenue (%): 15.63360157085503
Free cash flow (dilution-adjusted): 4350364.96350365
Buyback yield (%): 0
Retained earnings: -155398540.1459854
Inventory turnover: 13.560137457044673
Receivables turnover: 4.978311149901811
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.552306147786325
FCF margin (%): 2.612247760304354
Revenue growth (%): 6.902228994955513
Rule of 40 score: 9.514476755259867
Financial ratios for CVVY.TO — quarterly report dated 2025-12-31
Total revenue: 45486131.38686131
Gross profit: 41513138.68613138
Operating income: -862043.795620438
Net income: -1166423.3576642335
Capital expenditures: 7594160.583941605
Operating cash flow: 5675912.408759124
Depreciation & amortization: 266423.35766423354
Net tangible assets: 101129197.08029196
Owner earnings: -8494160.583941605
Return on net tangible assets (%): -8.399315755664142
Buffett classification: The Gruesome
Stock price: 0.6642335766423357
Shares outstanding: 309088041
Book value: 101129197.08029199
P/B ratio: 2.0301422427768188
Market cap (USD): 205306654.9708029
Debt to equity: 1.1212584898987346
Current ratio: 0.7878208455115773
Quick ratio: 0.7533757637010935
Effective tax rate (%): 136.0966794669076
Interest coverage ratio: -0.2390688259109312
COGS to revenue (%): 8.734514410424289
SG&A to revenue (%): 14.03170935233327
Free cash flow (dilution-adjusted): -6964233.576642334
Buyback yield (%): 0
Retained earnings: -155398540.1459854
Inventory turnover: 1.4388051810732223
Receivables turnover: 1.3597207069605062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.27509323121574436
FCF margin (%): -15.310674626099235
Revenue growth (%): 35.37249251201631
Rule of 40 score: 20.061817885917073
Financial ratios for CY5.AX — annual report dated 2021-12-31
Total revenue: 18031.159420289856
Gross profit: 18031.159420289856
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12318840579710147
Shares outstanding: 1227592052
Market cap (USD): 151225107.8550725
COGS to revenue (%): 0
Buyback yield (%): 0
Receivables turnover: 0.9913150870483246
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CY5.AX — annual report dated 2022-12-31
Total revenue: 62498.64864864865
Gross profit: 62498.64864864865
Operating income: -1761761.4864864864
Net income: -1567875
Capital expenditures: 891793.2432432432
Depreciation & amortization: 45327.02702702703
Net tangible assets: 11758406.081081081
Owner earnings: -2414341.2162162163
Return on net tangible assets (%): -20.532895356461776
Buffett classification: The Gruesome
Stock price: 0.25675675675675674
Shares outstanding: 1227592052
Book value: 11758406.081081081
P/B ratio: 26.805721091656046
Market cap (USD): 315192553.8918919
Debt to equity: 0
Current ratio: 4.302414024509506
Quick ratio: 4.302414024509506
COGS to revenue (%): 0
SG&A to revenue (%): 1641.0008865056543
Free cash flow (dilution-adjusted): -4553039.864864865
Buyback yield (%): 0.16331286816393334
Retained earnings: -10073980.405405406
Receivables turnover: 0.5529961080189159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.612877478239067
FCF margin (%): -7285.021297757789
Revenue growth (%): 246.6146973240169
Rule of 40 score: -7038.406600433773
Financial ratios for CY5.AX — annual report dated 2023-12-31
Total revenue: 5958.904109589042
Gross profit: 5958.904109589042
Operating income: -9742639.04109589
Net income: -9246778.08219178
Capital expenditures: 1285502.0547945206
Depreciation & amortization: 35261.643835616436
Net tangible assets: 18477668.493150685
Owner earnings: -10497018.493150683
Return on net tangible assets (%): -56.809215389061265
Buffett classification: The Gruesome
Stock price: 0.09589041095890412
Shares outstanding: 1227592052
Book value: 18579836.301369864
P/B ratio: 6.335594374826946
Market cap (USD): 117714306.3561644
Debt to equity: 0
Current ratio: 1.9427214046964847
Quick ratio: 1.9427214046964847
COGS to revenue (%): 0
SG&A to revenue (%): 132754.68965517238
Free cash flow (dilution-adjusted): -11253323.287671233
Buyback yield (%): 0.41348077601085204
Retained earnings: -19458758.219178084
Receivables turnover: 0.012512674476301427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.07786433975384
FCF margin (%): -188848.87356321837
Revenue growth (%): -90.46554727432833
Rule of 40 score: -188939.3391104927
Financial ratios for CY5.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 44389662.73291925
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 1227592052
Book value: 44389662.73291925
P/B ratio: 1.7176961672165936
Market cap (USD): 76247953.54037267
Debt to equity: 0
Current ratio: 4.479313748175993
Quick ratio: 4.479313748175993
Buyback yield (%): 0
Retained earnings: -19694045.96273292
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CY5.AX — annual report dated 2024-12-31
Operating income: -3228149.6894409936
Net income: -2343210.559006211
Capital expenditures: 174093.78881987577
Depreciation & amortization: 26152.173913043476
Net tangible assets: 44389662.73291925
Owner earnings: -2491152.173913043
Return on net tangible assets (%): -5.612009689962369
Buffett classification: The Gruesome
Stock price: 0.062111801242236024
Shares outstanding: 1227592052
Book value: 44389662.73291925
P/B ratio: 1.7176961672165936
Market cap (USD): 76247953.54037267
Debt to equity: 0
Current ratio: 4.479313748175993
Quick ratio: 4.479313748175993
Interest coverage ratio: -128.69752872424723
Free cash flow (dilution-adjusted): -6398309.316770186
Buyback yield (%): 0.5488598585354802
Retained earnings: -19694045.96273292
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.904394679340033
Rule of 40 score: 0
Financial ratios for DEBS.L — annual report dated 2022-02-28
Total revenue: 2643733333.3333335
Gross profit: 1388133333.3333333
Operating income: 12400000
Net income: -5333333.333333333
Capital expenditures: 306000000
Operating cash flow: 13733333.333333334
Depreciation & amortization: 71733333.33333333
Net tangible assets: 447733333.3333333
Owner earnings: -239600000
Return on net tangible assets (%): -53.51399642644431
Capex to operating income (%): 2467.7419354838707
Buffett classification: The Gruesome
Stock price: 0.011866666666666666
Shares outstanding: 1573007757
Book value: 619066666.6666666
P/B ratio: 0.030152420928925266
Market cap (USD): 18666358.716399997
Debt to equity: 0.32715916433340514
Current ratio: 0.9978340914013428
Quick ratio: 0.39267922893653884
Effective tax rate (%): 151.28205128205127
Interest coverage ratio: 5.8125
COGS to revenue (%): 47.49344361508977
SG&A to revenue (%): 51.39197095017147
Free cash flow (dilution-adjusted): -369733333.3333333
Buyback yield (%): 137.14511967193798
Retained earnings: 477066666.6666667
Inventory turnover: 3.3704366499642093
Receivables turnover: 57.30635838150289
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.732811626607043
FCF margin (%): -13.985273350817023
Rule of 40 score: -13.985273350817023
Financial ratios for DEBS.L — annual report dated 2023-02-28
Total revenue: 2130963855.421687
Gross profit: 1078554216.86747
Operating income: -99156626.5060241
Net income: -91084337.3493976
Capital expenditures: 70602409.63855422
Operating cash flow: 164698795.1807229
Depreciation & amortization: 82650602.40963855
Net tangible assets: 323493975.90361446
Owner earnings: -79036144.57831326
Return on net tangible assets (%): -24.43202979515829
Buffett classification: The Gruesome
Stock price: 0.006024096385542169
Shares outstanding: 1573007757
Book value: 481927710.84337354
P/B ratio: 0.0196625969625
Market cap (USD): 9475950.343373494
Debt to equity: 1.159
Current ratio: 1.6195973949082298
Quick ratio: 1.0923623445825932
Interest coverage ratio: -7.283185840707965
COGS to revenue (%): 49.38655509696387
SG&A to revenue (%): 54.58246169503025
Free cash flow (dilution-adjusted): 16265060.240963854
Buyback yield (%): 94.08726647493576
Retained earnings: 378554216.8674699
Inventory turnover: 4.904548006737787
Receivables turnover: 100.49431818181819
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.269061831287308
FCF margin (%): 0.7632724599988692
Revenue growth (%): -19.395658081184937
Rule of 40 score: -18.632385621186067
Financial ratios for DEBS.L — annual report dated 2024-02-29
Total revenue: 1142151898.734177
Gross profit: 606708860.7594936
Operating income: -192405063.29113925
Net income: -174177215.1898734
Capital expenditures: 18607594.93670886
Operating cash flow: 2405063.2911392404
Depreciation & amortization: 83924050.63291138
Net tangible assets: 222025316.4556962
Owner earnings: -108860759.49367088
Return on net tangible assets (%): -49.03078677309008
Buffett classification: The Gruesome
Stock price: 0.004303797468354431
Shares outstanding: 1573007757
Book value: 354050632.91139233
P/B ratio: 0.019121295580264576
Market cap (USD): 6769906.802278481
Debt to equity: 1.5977833392920988
Current ratio: 1.4283132530120481
Quick ratio: 0.8018072289156627
Interest coverage ratio: -7.169811320754718
COGS to revenue (%): 46.880195057076364
SG&A to revenue (%): 66.65188961542724
Free cash flow (dilution-adjusted): -64683544.30379747
Buyback yield (%): 286.07614806568307
Retained earnings: 245443037.97468352
Inventory turnover: 2.0336538461538463
Receivables turnover: 50.69101123595505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.446596717783162
FCF margin (%): -5.663304887509698
Revenue growth (%): -46.40209894558902
Rule of 40 score: -52.06540383309871